The "OPtimal management of anTIthroMbotic Agents (OPTIMA)-4" trial aims to address a critical challenge in the treatment of acute coronary syndrome (ACS) patients. Approximately 5%–15% of ACS patients undergoing stent...
Most Recent Articles
Efficacy of Catheter Ablation in Atrial Fibrillation Patients with Severe Heart Failure
This research paper addresses the uncharted territory of catheter ablation's efficacy in patients suffering from symptomatic atrial fibrillation combined with end-stage heart failure. The study was conducted as a single-center...
VISUALIZED: Comparative Analysis of Stent Platforms for High-Bleeding-Risk PCI Patients
Read further: Comparative Analysis of Stent Platforms for High-Bleeding-Risk PCI Patients
Comparative Analysis of Stent Platforms for High-Bleeding-Risk PCI Patients
This study aimed to assess the safety and efficacy of two distinct stent platforms, namely biodegradable-polymer sirolimus-eluting stents and durable-polymer zotarolimus-eluting stents, in patients at high risk for bleeding who...
Cardiac Function Improvement and Mortality Risk Factors in Post-AMI VSR Closure
This research paper assessed the effectiveness and safety of percutaneous closure procedures for ventricular septal rupture (VSR) after acute myocardial infarction (AMI). The study encompassed 81 patients who underwent...